Interaction of Impaired Coronary Flow Reserve and Cardiomyocyte Injury on Adverse Cardiovascular Outcomes in Patients Without Overt Coronary Artery Disease
暂无分享,去创建一个
R. Blankstein | V. Murthy | M. D. Di Carli | S. Dorbala | B. Everett | J. Hainer | C. Foster | M. Gaber | V. Taqueti | Venkatesh L Murthy | Sharmila Dorbala | Marcelo F Di Carli | Brendan M. Everett | Marcelo F. Di Carli | S. Dorbala
[1] R. Blankstein,et al. Abstract 15687: Myocardial Coronary Flow Reserve Predicts Adverse Clinical Outcomes Independently of Luminal Angiographic Score , 2013 .
[2] Akshay S. Desai,et al. Circulating Biomarkers in Patients with Heart Failure and Preserved Ejection Fraction , 2013, Current Heart Failure Reports.
[3] S. Hokimoto,et al. Coronary microvascular dysfunction and diastolic load correlate with cardiac troponin T release measured by a highly sensitive assay in patients with nonischemic heart failure. , 2013, Journal of the American College of Cardiology.
[4] W. Paulus,et al. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. , 2013, Journal of the American College of Cardiology.
[5] O. Rimoldi,et al. Inflammation and microvascular dysfunction in cardiac syndrome X patients without conventional risk factors for coronary artery disease. , 2013, JACC. Cardiovascular imaging.
[6] P. Ridker,et al. Inflammation, coronary flow reserve, and microvascular dysfunction: moving beyond cardiac syndrome X. , 2013, JACC. Cardiovascular imaging.
[7] S. Solomon,et al. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. , 2013, Journal of the American College of Cardiology.
[8] Jeroen J. Bax,et al. Third universal definition of myocardial infarction. , 2012, Global heart.
[9] Jeroen J. Bax,et al. Third universal definition of myocardial infarction. , 2012, European heart journal.
[10] R. Blankstein,et al. Association Between Coronary Vascular Dysfunction and Cardiac Mortality in Patients With and Without Diabetes Mellitus , 2012, Circulation.
[11] R. Blankstein,et al. Coronary vascular dysfunction and prognosis in patients with chronic kidney disease. , 2012, JACC. Cardiovascular imaging.
[12] O. Rimoldi,et al. The coronary circulation and blood flow in left ventricular hypertrophy. , 2012, Journal of molecular and cellular cardiology.
[13] U. Förstermann,et al. Nitric oxide synthases: regulation and function. , 2012, European heart journal.
[14] M. Pencina,et al. Improved Cardiac Risk Assessment With Noninvasive Measures of Coronary Flow Reserve , 2011, Circulation.
[15] P. Lamendola,et al. [Coronary microvascular dysfunction. An update]. , 2011, Recenti progressi in medicina.
[16] B. Chow,et al. Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. , 2011, Journal of the American College of Cardiology.
[17] N. Cook,et al. Sensitive Cardiac Troponin T Assay and the Risk of Incident Cardiovascular Disease in Women With and Without Diabetes Mellitus: The Women's Health Study , 2011, Circulation.
[18] M. Javadi,et al. Prediction of Short-Term Cardiovascular Events Using Quantification of Global Myocardial Flow Reserve in Patients Referred for Clinical 82Rb PET Perfusion Imaging , 2011, The Journal of Nuclear Medicine.
[19] W. Paulus,et al. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. , 2011, European heart journal.
[20] A. Khera,et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. , 2010, JAMA.
[21] M. Zhan,et al. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. , 2010, JAMA.
[22] Christopher M O'Connor,et al. Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. , 2010, Journal of the American College of Cardiology.
[23] M. Pfeffer,et al. A sensitive cardiac troponin T assay in stable coronary artery disease. , 2009, The New England journal of medicine.
[24] Tobias Reichlin,et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. , 2009, The New England journal of medicine.
[25] K. Gould,et al. Does coronary flow trump coronary anatomy? , 2009, JACC. Cardiovascular imaging.
[26] Oliver Gaemperli,et al. Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. , 2009, Journal of the American College of Cardiology.
[27] Georges El Fakhri,et al. Reproducibility and Accuracy of Quantitative Myocardial Blood Flow Assessment with 82Rb PET: Comparison with 13N-Ammonia PET , 2009, Journal of Nuclear Medicine.
[28] L. Lind,et al. Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects. , 2008, European heart journal.
[29] P. Jarolim,et al. Implementation of a highly sensitive cardiac troponin I assay: test volumes, positivity rates and interpretation of results. , 2008, Clinica chimica acta; international journal of clinical chemistry.
[30] G. Taffet,et al. Coronary Microvascular Dysfunction , 2007 .
[31] C. Lotan,et al. Acute coronary syndrome vs nonspecific troponin elevation: clinical predictors and survival analysis. , 2007, Archives of internal medicine.
[32] Keiichiro Yoshinaga,et al. What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography? , 2006, Journal of the American College of Cardiology.
[33] A. Khera,et al. Prevalence and Determinants of Troponin T Elevation in the General Population , 2006, Circulation.
[34] P. Venge,et al. Troponin I as a Predictor of Coronary Heart Disease and Mortality in 70-Year-Old Men: A Community-Based Cohort Study , 2006, Circulation.
[35] M. Whooley,et al. Prognostic value of low-level cardiac troponin-I elevations in patients without definite acute coronary syndromes , 2004 .
[36] M. Cerqueira,et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[37] M. Cerqueira,et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Circulation.
[38] O. Rimoldi,et al. Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans. , 2001, Cardiovascular research.
[39] S. Goldhaber,et al. Elevation of troponin I levels in patients without evidence of myocardial injury. , 1997, JAMA.
[40] A. Morise,et al. Development and validation of a clinical score to estimate the probability of coronary artery disease in men and women presenting with suspected coronary disease. , 1997, The American journal of medicine.
[41] I. Olivotto,et al. Effect of aging on myocardial perfusion reserve. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[42] P. Grambsch,et al. Martingale-based residuals for survival models , 1990 .
[43] A. Wear. CIRCULATION , 1964, The Lancet.
[44] J. Alpert,et al. The third universal definition of myocardial infarction , 2013 .
[46] L. Husmann,et al. Long-Term Prognostic Value of 13 N-Ammonia Myocardial Perfusion Positron Emission Tomography Added Value of Coronary Flow Reserve , 2022 .